NCT02500472View on ClinicalTrials.gov

Investigation of Kava Effects on NNK Metabolism

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 3, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Tobacco Smoking
Interventions
DIETARY_SUPPLEMENT

Kava

3 doses equaling 250 mg kavalactones per day. Participants will take 1 capsule three times daily at 8:00 (± 2 hours), 14:00 (± 2 hours) and 20:00 (± 2 hours) for 7 consecutive days.

Trial Locations (1)

55455

Masonic Cancer Center, University of Minnesota, Minneapolis

All Listed Sponsors
lead

Masonic Cancer Center, University of Minnesota

OTHER

NCT02500472 - Investigation of Kava Effects on NNK Metabolism | Biotech Hunter | Biotech Hunter